รายงานผู้ป่วย : Oral Non Hodgkin’s Lymphoma
บทคัดย่อ
รายงานผู้ป่วยฉบับนี้ เป็นชายไทยคู่ มาพบทันตแพทย์ด้วยอาการมีก้อนในช่องปากได้รับการวินิจฉัยว่าเป็น NHL ชนิด Diffuse Large B cell lymphoma (DLBCL) ร่วมกับการติดเชื้อ HIV โดยรายงานการวินิจฉัยชนิดย่อยของ NHLด้วยเทคนิคอิมมูโนฮิสโตเคมี และอินไซทูไฮบริไดเซชัน ไวรัส อีวีบี
เอกสารอ้างอิง
1. Epstein, J. B., Epstein, J.D., Le, N. D., & Gorsky, M. Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92(5),519-25. (cite 2015 Jan, 15) Available From: doi:10.1067/moe.2001.116062
2. Warnakulasuriya, S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009;45(4-5),309-16. (cite 2015 Jan, 15) Available From: doi:10.1016/j.oraloncology. 2008.06.002
3. Carbone, A., Cesarman, E., Spina, M., Gloghini, A., & Schulz, T.F. HIV-associated lymphomas and gamma-herpesviruses. Blood 2009;113(6),1213-24. (cite 2015 Jan,9) Available From: doi: 10.1182/blood-2008-09-180315
4. Kemp, S., Gallagher, G., Kabani, S., Noonan, V., & O’Hara, C. Oral non-Hodgkin’s lymphoma: review of the literature and World Health Organization classification with reference to 40 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 2008;105(2), 194-201. (cite 2015 Jan,9) Available From: doi:10.1016/j.tripleo.2007.02.019
5. Etemad-Moghadam, S., Tirgary, F., Keshavarz, S., & Alaeddini, M. Head and neck non- Hodgkin’s lymphoma: a 20-year demographic study of 381 cases. Int J Oral Maxillofac Surg 2010;39(9),869-72. (cite 2015 Jan, 20) Available From: doi:10.1016/j.ijom.2010.03.029
6. Boulaadas, M., Benazzou, S., Sefiani, S., Nazih, N., Essakalli, L., & Kzadri, M. Primary extranodal non-Hodgkin lymphoma of the oral cavity. J Craniofac Surg 2008;19(4),1183-5.doi:10.1097/SCS.0b013e3181764b56
7. Ramanathan, A., Rahman Mahmoud, H.A., Hui, L. P., Mei, N.Y.,Valliappan, V.,& Zain, R.B. Oral Extranodal Non Hodgkin’s Lymphoma:Series of Forty Two Cases in Malaysia. Asian Pac J Cancer Prev 2014;15(4),1633-7.
8. Epstein, J.B. Oral malignancies associated with HIV. J Can Dent Assoc 2007;73(10),953-6.
9. Cuttner, J., Spiera, H., Troy, K.,& Wallenstein, S. Autoimmune disease is a risk factor for the development of non-Hodgkin’s lymphoma. J Rheumatol 2005;32(10),1884-7.
10. Fisher, S.G., & Fisher, R.I. The epidemiology of non-Hodgkin’s lymphoma. Oncogene 2004;23(38),6524-34. (cite 2015 Feb,2) Available from:doi:10.1038/sj.onc.1207843
11. Kiertiburanakul, S., Likhitpongwit, S., Ratanasiri, S., & Sungkanuparph, S. Malignancies in HIV-infected Thai patients. HIV Med 2007;8(5),322-23. (cite 2015 Feb,2) Available From: doi:10.1111/j.1468-1293.2007.00471.x
12. Nisa Makruasi, Pimjai Niparuck, Somnuek Sungkanuparph, Artit Ungkanont, Wasana Kanoksil, Paisarn Boonsakan et al, Non Hodgkin’s Lymphoma (NHL) in HIV Infected
Patients in Thailand 2011 J INFECT DIS ANTIMICROB AGENTS 2011;(Jan.-April),5-14.
13. Carbone, A., & Gloghini, A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 2005;130(5),662-70. (cite 2015 Feb,2) Available From:doi: 10.1111/j.1365-2141.2005.05613.x
14. Gaidano, G., & Carbone, A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 1995;90(2),235-43.
15. Sharma, M., Mannan, R., Madhukar, M., Navani, S., Manjari, M., Bhasin,T.S., & Gill, K.S. Immunohistochemical (IHC) Analysis of Non-Hodgkin’s Lymphoma (NHL) Spectrum According to WHO/REAL Classification: A Single Centre Experience from Punjab, India. J Clin Diagn Res 2014;8(1),46-9. (cite 2015 Feb,8) Available From: doi:10.7860/JCDR/2014/8173.3988
16. van der Waal, R.I., Huijgens, P.C., van der Valk, P., & van der Waal, I. Characteristics of 40 primary extranodal non-Hodgkin lymphomas of the oral cavity in perspective of the new WHO classification and the International Prognostic Index. Int J Oral Maxillofac Surg 2005;34(4),391-5. (cite 2015 Feb,8) Available From:doi:10.1016/j.ijom.2004.08.009
17. Souto, G.R., Pereira, T.S., Castro, A.F.,& Mesquita, R.A.Diffuse large B-cell lymphoma, not otherwise specified of the palate: A case report. J Clin Exp Dent 2013;5(5),e287-90. (cite 2015 Feb,8) Available From:doi:10.4317/jced.51127
18. Bulut,E., Bekcioglu,B., Gunhan, O., & Sener, I. Diffuse large B-cell lymphoma with oral manifestations. J Craniofac Surg 2011;22(3),1144-7.(cite 2015 Feb,8) Available From:doi:10.1097/SCS.0b013e318210b940
19. Pileri, S.A., Dirnhofer, S.,Went, P., Ascani, S., Sabattini, E., Marafioti, T.,et al. Diffuse large B-cell lymphoma:one or more entities? Present controversies and possible tools for its subclassification. Histopathology 2002;41(6),482-509.
20. Iamaroon, A., Pongsiriwet, S., Mahanupab,P.,Kitikamthon, R., & Pintong, J. (1982). Oral non-Hodgkin lymphomas: studies of EBV and p53 expression. Oral Dis 1982;9(1),14-8.
21. Chadburn A, Chiu A,& JY, L.(2009). Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. J Clin Oncol, 27,27:5039-48.
22. Shimizu, K., Hara, K., & Kunii, A. Weekly CHOP for the treatment of advanced intermediate and high-grade non-Hodgkin’s lymphoma. Am J Clin Oncol 1989;12(3),195-200
23. Tirelli, U., Errante, D., Van Glabbeke, M., Teodorovic, I., Kluin-Nelemans, J.C., Thomas, J., et al. (1998). CHOP is the standard regimen in patients>or = 70 years of age with intermediate-grade and high-grade non-Hodgkin’s lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. J Clin Oncol 1998;16(1),27-34.
24. Kamath, S.S., Marcus, R.B., Jr., Lynch, J. W., & Mendenhall, N.P. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in
stage I and II non-Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 1999;44(3),563-8.
25. Whelton, S. Radioimmunotherapy in the treatment of non-Hodgkin’s lymphoma. Nurse Pract 2007;32(12),35-8. (cite 2015 Feb,8) Available From:doi:10.1097/01.NPR.0000300826.51593.f4
2. Warnakulasuriya, S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009;45(4-5),309-16. (cite 2015 Jan, 15) Available From: doi:10.1016/j.oraloncology. 2008.06.002
3. Carbone, A., Cesarman, E., Spina, M., Gloghini, A., & Schulz, T.F. HIV-associated lymphomas and gamma-herpesviruses. Blood 2009;113(6),1213-24. (cite 2015 Jan,9) Available From: doi: 10.1182/blood-2008-09-180315
4. Kemp, S., Gallagher, G., Kabani, S., Noonan, V., & O’Hara, C. Oral non-Hodgkin’s lymphoma: review of the literature and World Health Organization classification with reference to 40 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 2008;105(2), 194-201. (cite 2015 Jan,9) Available From: doi:10.1016/j.tripleo.2007.02.019
5. Etemad-Moghadam, S., Tirgary, F., Keshavarz, S., & Alaeddini, M. Head and neck non- Hodgkin’s lymphoma: a 20-year demographic study of 381 cases. Int J Oral Maxillofac Surg 2010;39(9),869-72. (cite 2015 Jan, 20) Available From: doi:10.1016/j.ijom.2010.03.029
6. Boulaadas, M., Benazzou, S., Sefiani, S., Nazih, N., Essakalli, L., & Kzadri, M. Primary extranodal non-Hodgkin lymphoma of the oral cavity. J Craniofac Surg 2008;19(4),1183-5.doi:10.1097/SCS.0b013e3181764b56
7. Ramanathan, A., Rahman Mahmoud, H.A., Hui, L. P., Mei, N.Y.,Valliappan, V.,& Zain, R.B. Oral Extranodal Non Hodgkin’s Lymphoma:Series of Forty Two Cases in Malaysia. Asian Pac J Cancer Prev 2014;15(4),1633-7.
8. Epstein, J.B. Oral malignancies associated with HIV. J Can Dent Assoc 2007;73(10),953-6.
9. Cuttner, J., Spiera, H., Troy, K.,& Wallenstein, S. Autoimmune disease is a risk factor for the development of non-Hodgkin’s lymphoma. J Rheumatol 2005;32(10),1884-7.
10. Fisher, S.G., & Fisher, R.I. The epidemiology of non-Hodgkin’s lymphoma. Oncogene 2004;23(38),6524-34. (cite 2015 Feb,2) Available from:doi:10.1038/sj.onc.1207843
11. Kiertiburanakul, S., Likhitpongwit, S., Ratanasiri, S., & Sungkanuparph, S. Malignancies in HIV-infected Thai patients. HIV Med 2007;8(5),322-23. (cite 2015 Feb,2) Available From: doi:10.1111/j.1468-1293.2007.00471.x
12. Nisa Makruasi, Pimjai Niparuck, Somnuek Sungkanuparph, Artit Ungkanont, Wasana Kanoksil, Paisarn Boonsakan et al, Non Hodgkin’s Lymphoma (NHL) in HIV Infected
Patients in Thailand 2011 J INFECT DIS ANTIMICROB AGENTS 2011;(Jan.-April),5-14.
13. Carbone, A., & Gloghini, A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 2005;130(5),662-70. (cite 2015 Feb,2) Available From:doi: 10.1111/j.1365-2141.2005.05613.x
14. Gaidano, G., & Carbone, A. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 1995;90(2),235-43.
15. Sharma, M., Mannan, R., Madhukar, M., Navani, S., Manjari, M., Bhasin,T.S., & Gill, K.S. Immunohistochemical (IHC) Analysis of Non-Hodgkin’s Lymphoma (NHL) Spectrum According to WHO/REAL Classification: A Single Centre Experience from Punjab, India. J Clin Diagn Res 2014;8(1),46-9. (cite 2015 Feb,8) Available From: doi:10.7860/JCDR/2014/8173.3988
16. van der Waal, R.I., Huijgens, P.C., van der Valk, P., & van der Waal, I. Characteristics of 40 primary extranodal non-Hodgkin lymphomas of the oral cavity in perspective of the new WHO classification and the International Prognostic Index. Int J Oral Maxillofac Surg 2005;34(4),391-5. (cite 2015 Feb,8) Available From:doi:10.1016/j.ijom.2004.08.009
17. Souto, G.R., Pereira, T.S., Castro, A.F.,& Mesquita, R.A.Diffuse large B-cell lymphoma, not otherwise specified of the palate: A case report. J Clin Exp Dent 2013;5(5),e287-90. (cite 2015 Feb,8) Available From:doi:10.4317/jced.51127
18. Bulut,E., Bekcioglu,B., Gunhan, O., & Sener, I. Diffuse large B-cell lymphoma with oral manifestations. J Craniofac Surg 2011;22(3),1144-7.(cite 2015 Feb,8) Available From:doi:10.1097/SCS.0b013e318210b940
19. Pileri, S.A., Dirnhofer, S.,Went, P., Ascani, S., Sabattini, E., Marafioti, T.,et al. Diffuse large B-cell lymphoma:one or more entities? Present controversies and possible tools for its subclassification. Histopathology 2002;41(6),482-509.
20. Iamaroon, A., Pongsiriwet, S., Mahanupab,P.,Kitikamthon, R., & Pintong, J. (1982). Oral non-Hodgkin lymphomas: studies of EBV and p53 expression. Oral Dis 1982;9(1),14-8.
21. Chadburn A, Chiu A,& JY, L.(2009). Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. J Clin Oncol, 27,27:5039-48.
22. Shimizu, K., Hara, K., & Kunii, A. Weekly CHOP for the treatment of advanced intermediate and high-grade non-Hodgkin’s lymphoma. Am J Clin Oncol 1989;12(3),195-200
23. Tirelli, U., Errante, D., Van Glabbeke, M., Teodorovic, I., Kluin-Nelemans, J.C., Thomas, J., et al. (1998). CHOP is the standard regimen in patients>or = 70 years of age with intermediate-grade and high-grade non-Hodgkin’s lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group. J Clin Oncol 1998;16(1),27-34.
24. Kamath, S.S., Marcus, R.B., Jr., Lynch, J. W., & Mendenhall, N.P. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in
stage I and II non-Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 1999;44(3),563-8.
25. Whelton, S. Radioimmunotherapy in the treatment of non-Hodgkin’s lymphoma. Nurse Pract 2007;32(12),35-8. (cite 2015 Feb,8) Available From:doi:10.1097/01.NPR.0000300826.51593.f4
ดาวน์โหลด
เผยแพร่แล้ว
2019-01-10
รูปแบบการอ้างอิง
1.
เสกธีระ ก, ทรัพยะโตษก ไ, รังสิยานนท์ ส, บุญสะกันต์ ไ. รายงานผู้ป่วย : Oral Non Hodgkin’s Lymphoma. JPMAT [อินเทอร์เน็ต]. 10 มกราคม 2019 [อ้างถึง 13 มกราคม 2026];5(2):188-95. available at: https://he01.tci-thaijo.org/index.php/JPMAT/article/view/165702
ฉบับ
ประเภทบทความ
รายงานผู้ป่วย
สัญญาอนุญาต
บทความที่ลงพิมพ์ในวารสารเวชศาสตร์ป้องกันแห่งประเทศไทย ถือเป็นผลงานวิชาการ งานวิจัย วิเคราะห์ วิจารณ์ ตลอดจนเป็นความเห็นส่วนตัวของผู้นิพนธ์ กองบรรณาธิการไม่จำเป็นต้องเห็นด้วยเสมอไป และผู้นิพนธ์จะต้องรับผิดชอบต่อบทความของตนเอง
